Landos Biopharma Inc (LABP)
22.30
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
22.30
0.00 (0.00%)
After-Hours: 20:00
Landos Biopharma Total Liabilities (Quarterly): 6.742M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 6.742M |
| December 31, 2023 | 6.249M |
| September 30, 2023 | 5.566M |
| June 30, 2023 | 3.015M |
| March 31, 2023 | 4.16M |
| December 31, 2022 | 6.122M |
| September 30, 2022 | 5.475M |
| June 30, 2022 | 6.51M |
| Date | Value |
|---|---|
| March 31, 2022 | 15.51M |
| December 31, 2021 | 16.61M |
| September 30, 2021 | 11.18M |
| June 30, 2021 | 12.68M |
| March 31, 2021 | 9.031M |
| December 31, 2020 | 84.35M |
| September 30, 2020 | 81.00M |
| December 31, 2019 | 76.06M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.015M
Minimum
Jun 2023
84.35M
Maximum
Dec 2020
21.89M
Average
7.886M
Median
Total Liabilities (Quarterly) Benchmarks
| AbbVie Inc | 140.83B |
| Fusion Pharmaceuticals Inc | 81.98M |
| Masimo Corp | 1.592B |
| Kinnate Biopharma Inc (DELISTED) | 14.28M |
| Invivyd Inc | 36.97M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.90M |
| Shareholders Equity (Quarterly) | 23.15M |